3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Carcinoma, Renal Cell
6
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Hematologic Neoplasms
2
Carcinoma, Basal Cell
2
Xeroderma Pigmentosum
1
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Somatostatinoma
1
Sjogren's Syndrome
1
Seminoma
1
Scleroderma, Systemic
1
Sarcoma
1
Recurrent Squamous Cell Lung Carcinoma
1
Rectal Neoplasms
1
Rare Diseases
1
Psoriasis
1
Pseudomyxoma Peritonei
1
Pheochromocytoma
1
Interventions
Rituximab
4
Cladribine
2
tovorafenib
1
polatuzumab vedotin
1
obinutuzumab
1
immunotoxin HA22
1
ibrutinib
1
encorafenib
1
binimetinib
1
Vemurafenib
1
Specimen Handling
1
Prednisone
1
Lenalidomide
1
Famotidine
1
Doxorubicin
1
Diphenhydramine
1
Dexamethasone
1
Cyclophosphamide
1
Calcium Dobesilate
1
CT-P10
1
Biopsy
1
Aspirin
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
CTLA-4 Antigen
×
30 days
×
Clear all
No trials found.